Annual Cash & Cash Equivalents
$9.79 M
+$7.67 M+361.09%
December 31, 2023
Summary
- As of February 8, 2025, TENX annual cash & cash equivalents is $9.79 million, with the most recent change of +$7.67 million (+361.09%) on December 31, 2023.
- During the last 3 years, TENX annual cash & cash equivalents has risen by +$3.54 million (+56.67%).
- TENX annual cash & cash equivalents is now -83.21% below its all-time high of $58.32 million, reached on April 30, 2014.
Performance
TENX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$98.31 M
+$88.93 M+947.64%
September 30, 2024
Summary
- As of February 8, 2025, TENX quarterly cash and cash equivalents is $98.31 million, with the most recent change of +$88.93 million (+947.64%) on September 30, 2024.
- Over the past year, TENX quarterly cash and cash equivalents has increased by +$85.76 million (+683.38%).
- TENX quarterly cash and cash equivalents is now at all-time high.
Performance
TENX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TENX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +361.1% | +683.4% |
| 3 y3 years | +56.7% | +634.0% |
| 5 y5 years | -20.8% | +634.0% |
TENX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +361.1% | at high | +4529.2% |
| 5 y | 5-year | at high | +361.1% | at high | +5781.9% |
| alltime | all time | -83.2% | >+9999.0% | at high | >+9999.0% |
Tenax Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $98.31 M(+947.6%) |
| Jun 2024 | - | $9.38 M(-25.2%) |
| Mar 2024 | - | $12.55 M(+28.2%) |
| Dec 2023 | $9.79 M(+361.1%) | $9.79 M(-12.1%) |
| Sep 2023 | - | $11.14 M(-16.8%) |
| Jun 2023 | - | $13.39 M(-7.1%) |
| Mar 2023 | - | $14.41 M(+578.8%) |
| Dec 2022 | $2.12 M(-62.0%) | $2.12 M(-44.2%) |
| Sep 2022 | - | $3.81 M(-47.3%) |
| Jun 2022 | - | $7.23 M(+152.0%) |
| Mar 2022 | - | $2.87 M(-48.6%) |
| Dec 2021 | $5.58 M(-10.7%) | $5.58 M(-33.2%) |
| Sep 2021 | - | $8.35 M(+399.8%) |
| Jun 2021 | - | $1.67 M(-52.7%) |
| Mar 2021 | - | $3.54 M(-43.4%) |
| Dec 2020 | $6.25 M(+27.4%) | $6.25 M(-24.1%) |
| Sep 2020 | - | $8.24 M(+101.6%) |
| Jun 2020 | - | $4.09 M(-6.3%) |
| Mar 2020 | - | $4.36 M(-11.2%) |
| Dec 2019 | $4.91 M(-60.3%) | $4.91 M(-26.2%) |
| Sep 2019 | - | $6.65 M(-20.9%) |
| Jun 2019 | - | $8.41 M(-18.6%) |
| Mar 2019 | - | $10.32 M(-16.5%) |
| Dec 2018 | $12.37 M(+670.6%) | $12.37 M(+269.5%) |
| Sep 2018 | - | $3.35 M(-14.2%) |
| Jun 2018 | - | $3.90 M(+30.4%) |
| Mar 2018 | - | $2.99 M(+86.5%) |
| Dec 2017 | $1.60 M(-83.9%) | $1.60 M(-9.0%) |
| Sep 2017 | - | $1.76 M(-21.0%) |
| Jun 2017 | - | $2.23 M(-68.2%) |
| Mar 2017 | - | $7.03 M(-29.7%) |
| Dec 2016 | $10.00 M(+173.1%) | $10.00 M(+1284.1%) |
| Sep 2016 | - | $722.20 K(-62.5%) |
| Jun 2016 | - | $1.93 M(-40.9%) |
| Mar 2016 | - | $3.26 M(-36.0%) |
| Dec 2015 | $3.66 M(-53.8%) | - |
| Oct 2015 | - | $5.10 M(+39.7%) |
| Jul 2015 | - | $3.65 M(-53.9%) |
| Apr 2015 | $7.93 M(-86.4%) | $7.93 M(-20.1%) |
| Jan 2015 | - | $9.92 M(-30.9%) |
| Oct 2014 | - | $14.36 M(-34.6%) |
| Jul 2014 | - | $21.96 M(-62.4%) |
| Apr 2014 | $58.32 M(+7343.6%) | $58.32 M(+819.9%) |
| Jan 2014 | - | $6.34 M(+149.3%) |
| Oct 2013 | - | $2.54 M(-37.6%) |
| Jul 2013 | - | $4.07 M(+419.8%) |
| Apr 2013 | $783.50 K(-58.3%) | $783.50 K(-5.5%) |
| Jan 2013 | - | $828.80 K(-45.2%) |
| Oct 2012 | - | $1.51 M(-43.8%) |
| Jul 2012 | - | $2.69 M(+43.2%) |
| Apr 2012 | $1.88 M | $1.88 M(-42.7%) |
| Jan 2012 | - | $3.28 M(+63.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2011 | - | $2.00 M(-49.9%) |
| Jul 2011 | - | $4.00 M(+320.0%) |
| Apr 2011 | $951.90 K(+50.5%) | $951.90 K(+82.3%) |
| Jan 2011 | - | $522.30 K(-37.6%) |
| Oct 2010 | - | $837.20 K(-69.4%) |
| Jul 2010 | - | $2.73 M(+331.8%) |
| Apr 2010 | $632.70 K(-75.2%) | $632.70 K(-78.0%) |
| Jan 2010 | - | $2.88 M(+195.0%) |
| Oct 2009 | - | $975.00 K(-61.0%) |
| Jul 2009 | - | $2.50 M(-2.1%) |
| Apr 2009 | $2.56 M(-47.6%) | $2.56 M(-38.4%) |
| Jan 2009 | - | $4.15 M(-20.3%) |
| Oct 2008 | - | $5.20 M(-14.5%) |
| Jul 2008 | - | $6.09 M(+24.7%) |
| Apr 2008 | $4.88 M(>+9900.0%) | $4.88 M(+419.1%) |
| Jan 2008 | - | $940.20 K(>+9900.0%) |
| Oct 2007 | - | $700.00(0.0%) |
| Jul 2007 | - | $700.00(-95.7%) |
| Apr 2007 | $16.20 K(+3950.0%) | $16.20 K(-26.7%) |
| Jan 2007 | - | $22.10 K(-78.3%) |
| Oct 2006 | - | $101.80 K(+1222.1%) |
| Jul 2006 | - | $7700.00(+1825.0%) |
| Apr 2006 | $400.00(-99.9%) | $400.00(-99.7%) |
| Jan 2006 | - | $152.70 K(-78.6%) |
| Oct 2005 | - | $712.00 K(-44.4%) |
| Jul 2005 | - | $1.28 M(+117.6%) |
| Apr 2005 | $588.80 K(+94.8%) | $588.80 K(-44.0%) |
| Jan 2005 | - | $1.05 M(+854.5%) |
| Oct 2004 | - | $110.10 K(-79.5%) |
| Jul 2004 | - | $536.60 K(+77.5%) |
| Apr 2004 | $302.30 K(+69.5%) | $302.30 K(-58.2%) |
| Jan 2004 | - | $722.50 K(+52.8%) |
| Oct 2003 | - | $472.80 K(-41.9%) |
| Jul 2003 | - | $813.70 K(+356.1%) |
| Apr 2003 | $178.40 K(-92.7%) | $178.40 K(-66.0%) |
| Jan 2003 | - | $524.40 K(-49.3%) |
| Oct 2002 | - | $1.04 M(-48.8%) |
| Jul 2002 | - | $2.02 M(-17.3%) |
| Apr 2002 | $2.44 M(-42.6%) | $2.44 M(-16.0%) |
| Jan 2002 | - | $2.91 M(-16.8%) |
| Oct 2001 | - | $3.50 M(-12.8%) |
| Jul 2001 | - | $4.01 M(-5.7%) |
| Apr 2001 | $4.25 M(-22.2%) | $4.25 M(-9.4%) |
| Jan 2001 | - | $4.69 M(-7.9%) |
| Oct 2000 | - | $5.10 M(-8.5%) |
| Jul 2000 | - | $5.57 M(+1.9%) |
| Apr 2000 | $5.47 M(+2633.2%) | $5.47 M(+2633.2%) |
| Oct 1999 | - | $200.00 K(+100.0%) |
| Jul 1999 | - | $100.00 K |
| Apr 1999 | $200.00 K(-73.0%) | - |
| Apr 1998 | $740.20 K(+1273.3%) | - |
| Apr 1997 | $53.90 K(-29.4%) | - |
| Apr 1996 | $76.30 K | - |
FAQ
- What is Tenax Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Tenax Therapeutics?
- What is Tenax Therapeutics annual cash & cash equivalents year-on-year change?
- What is Tenax Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Tenax Therapeutics?
- What is Tenax Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Tenax Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of TENX is $9.79 M
What is the all time high annual cash & cash equivalents for Tenax Therapeutics?
Tenax Therapeutics all-time high annual cash & cash equivalents is $58.32 M
What is Tenax Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, TENX annual cash & cash equivalents has changed by +$7.67 M (+361.09%)
What is Tenax Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TENX is $98.31 M
What is the all time high quarterly cash and cash equivalents for Tenax Therapeutics?
Tenax Therapeutics all-time high quarterly cash and cash equivalents is $98.31 M
What is Tenax Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, TENX quarterly cash and cash equivalents has changed by +$85.76 M (+683.38%)